Return to Publications
July 2017
RWJBarnabas HealthRutgers Cancer Institute, along with its partner RWJBarnabas Health, offers the most advanced cancer treatment options including clinical trials and novel therapeutics such as precision medicine and immunotherapy.
Top Docs

Top Honors for Rutgers Cancer Institute of New Jersey Physicians

Several Rutgers Cancer Institute of New Jersey oncologists have been recognized as a 'top cancer doctor' in the annual listing by Inside Jersey magazine. Selected on attributes including training, board certification, years in practice, and clinical skills, Rutgers Cancer Institute specialists were selected by a physician-led research team assembled by Castle Connolly Ltd.

Rabinowitz and White

$2.24M Grant Awarded to Rutgers Cancer Institute of New Jersey Researchers

A $2.24 million competing renewal grant from the National Cancer Institute will support the work of investigators at Rutgers Cancer Institute of New Jersey and Princeton University to learn more about the fuel required for tumor growth. The collaborative research between Eileen White, PhD, deputy director, chief scientific officer, and associate director for basic science at Rutgers Cancer Institute; and Joshua D. Rabinowitz, MD, PhD, professor in the Department of Chemistry and Lewis-Sigler Institute for Integrative Genomics at Princeton University and research member at Rutgers Cancer Institute, will focus on melanoma and lung cancer caused by mutations in genes known as K-ras and Braf.


A Closer Look at Hair Products and Breast Cancer Risk

Can use of hair products have an impact on breast cancer risk for women? That is a question explored by Rutgers University investigators and other colleagues who examined the use of hair dyes, hair relaxers and cholesterol-based hair products in African-American and Caucasian women. The study's lead author Adana Llanos, PhD, MPH, a researcher at Rutgers Cancer Institute of New Jersey and Rutgers School of Public Health, shares more about the work, which appeared in the June 2017 online issue of Carcinogenesis.


Treatment Advances Help Improve Childhood Cancer Survival in New Jersey

The latest childhood cancer statistics in New Jersey show significant declines in mortality rates for white, black and Hispanic children from 1979 to 2013. New Jersey State Cancer Registry Director Antoinette Stroup, PhD, of Rutgers Cancer Institute of New Jersey and Pamela Agovino, MPH, from the Cancer Surveillance Unit at the New Jersey Department of Health, say this improvement in survival can be attributed to treatment advances and participation in clinical trials.

Survivors Day

Life Lessons on and off the Court

More than 250 guests attended Rutgers Cancer Institute of New Jersey's annual Cancer Survivors Day Celebration at the Hyatt New Brunswick in early June. Rutgers University women's basketball coach C. Vivian Stringer served as this year's keynote speaker and shared with the audience her life experiences including a bout with breast cancer and personal triumphs and adversities that have inspired her to rise above. Cancer survivors reunited with friends and caregivers, including Rutgers Cancer Institute healthcare team members.